| J9271 | Injection, pembrolizumab, 1 mg | 18,800 | $40 | $808.4K |
| J0897 | Injection, denosumab, 1 mg | 9,960 | $20 | $179.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 780 | $60 | $47K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 480 | $90 | $43.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 420 | $100 | $41.9K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 420 | $80 | $33.2K |
| J9394 | Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | 1,500 | $20 | $22.5K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,660 | $10 | $16.6K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 2,020 | $10 | $16.2K |
| 86300 | The lab analyst performs a quantitative test to evaluate the patient’s serum for the cancer tumor antigen CA 15 3, a tumor marker for breast cancer, and a similar marker called CA 27.29. | 780 | $20 | $15.5K |